Study protocol of the PROUD48 study comparing the effects of pemafibrate and omega-3 fatty acid ethyl esters on ApoB-48 in statin-treated patients with dyslipidaemia: a prospective, multicentre, open-label, randomised, parallel group trial in Japan

INTRODUCTION: This study will compare the lowering effects of pemafibrate and omega-3 fatty acid ethyl esters on fasting apolipoprotein B-48 (apoB-48), a surrogate marker reflecting postprandial hypertriglyceridaemia, which is a residual risk for atherosclerotic cardiovascular disease with statin tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeda, Yasutaka, Sakuma, Ichiro, Hiramitsu, Shinya, Okada, Mizuho, Ueda, Shinichiro, Sakurai, Masaru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664276/
https://www.ncbi.nlm.nih.gov/pubmed/36375977
http://dx.doi.org/10.1136/bmjopen-2022-061360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664276/
https://www.ncbi.nlm.nih.gov/pubmed/36375977
http://dx.doi.org/10.1136/bmjopen-2022-061360

Ejemplares similares